| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 110.53% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 11/15/2022 | 461.4% | Alliance Global Partners | $14 → $8 | Maintains | Buy |
| 06/28/2022 | 321.05% | Cantor Fitzgerald | $10 → $6 | Maintains | Overweight |
| 07/21/2021 | 1163.16% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2019 | 742.11% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 04/08/2019 | 215.79% | Alliance Global Partners | → $4.5 | Initiates Coverage On | → Buy |
| 11/01/2018 | 812.28% | Oppenheimer | → $13 | Initiates Coverage On | → Outperform |
What is the target price for SELLAS Life Sciences Gr (SLS)?
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 110.53% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $1.43, which is within the analyst's predicted range.